Brief: Eyenovia Announces Launch, Commercial Availability Of Clobetasol Propionate Ophthalmic Suspension
Sept 26 (Reuters) - Eyenovia Inc EYEN.O :
* EYENOVIA ANNOUNCES LAUNCH, COMMERCIAL AVAILABILITY OF
CLOBETASOL
PROPIONATE OPHTHALMIC SUSPENSION 0.05%
Source text for Eikon: ID:nGNXbkjxgf
Further company coverage: EYEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperion DeFi
See all newsHyperion DeFi Inc reports results for the quarter ended September 30 - Earnings Summary
Hyperion DeFi posts third straight record quarterly profit
Hyperion DeFi Inc expected to post earnings of $1.81 a share - Earnings Preview
Brief: Hyperion Defi Raises Guidance And Announces $20M Share Repurchase Program
Hyperion DeFi Inc reports results for the quarter ended June 30 - Earnings Summary